Conjunctival Lymphoma

[1]  F. Awan,et al.  Single-Agent Rituximab and Ultra-Low-Dose Adaptive Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma , 2021, Blood.

[2]  P. Hoskin,et al.  4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. , 2021, The Lancet. Oncology.

[3]  Ronald M. Mancini,et al.  Conjunctival Lymphoma With Nasal Spread Through the Nasolacrimal Duct. , 2020, Ophthalmic plastic and reconstructive surgery.

[4]  D. Vavvas,et al.  Paediatric ocular adnexal lymphoma: a population-based analysis , 2020, BMJ open ophthalmology.

[5]  J. S. Lee,et al.  Prognostic factors for relapse and survival among patients with ocular adnexal lymphoma: validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM classification , 2020, British Journal of Ophthalmology.

[6]  T. Calimeri,et al.  Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum. , 2020, Blood advances.

[7]  V. Elner,et al.  Intralesional Rituximab Injection for Low-Grade Conjunctival Lymphoma Management. , 2020, Ophthalmology.

[8]  M. Raderer,et al.  Experience with clarithromycin as antineoplastic therapy for extranodal marginal zone B‐cell lymphoma of the mucosa associated lymphoid tissue (MALT‐lymphoma) outside of clinical trials: Real‐world data from the University of Vienna , 2020, Hematological oncology.

[9]  A. Tzankov,et al.  High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B‐cell lymphomas , 2020, Hematological oncology.

[10]  N. Çetingül,et al.  Extranodal Ocular Adnexal Marginal Zone Lymphoma in a Ten-Year-Old Child , 2020, Turkish journal of ophthalmology.

[11]  A. Salar,et al.  Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  A. Bagg,et al.  Conjunctival Pediatric-Type Follicular Lymphoma. , 2019, Ophthalmic plastic and reconstructive surgery.

[13]  D. Strianese,et al.  Conjunctival Pediatric Follicular Lymphoma: Case Report and Literature Review. , 2019, Ophthalmic plastic and reconstructive surgery.

[14]  Sander R. Dubovy,et al.  Classification, diagnosis, and management of conjunctival lymphoma , 2019, Eye and Vision.

[15]  Sander R. Dubovy,et al.  The use of high resolution anterior segment optical coherence tomography for the characterization of conjunctival lymphoma, conjunctival amyloidosis and benign reactive lymphoid hyperplasia , 2019, Eye and Vision.

[16]  K. Maruyama,et al.  Conjunctival dysbiosis in mucosa-associated lymphoid tissue lymphoma , 2019, Scientific Reports.

[17]  H. Grossniklaus,et al.  International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma , 2019, British Journal of Ophthalmology.

[18]  Seok-Goo Cho,et al.  Refractory follicular conjunctival lesions: overlook as just inflammation or not? , 2019, British Journal of Ophthalmology.

[19]  S. Heegaard,et al.  Orbital lymphoma. , 2019, Survey of ophthalmology.

[20]  Y. Ko,et al.  Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[21]  Shih-Ming Jung,et al.  Conjunctival lymphoma during pregnancy: a case report , 2017, BMC Ophthalmology.

[22]  Michael L. Wang,et al.  Ultra–low‐dose radiotherapy for definitive management of ocular adnexal B‐cell lymphoma , 2017, Head & neck.

[23]  G. Salles,et al.  Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  C. Shields,et al.  Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in Children , 2017, JAMA ophthalmology.

[25]  C. Shields,et al.  Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture. , 2017, Asia-Pacific journal of ophthalmology.

[26]  M. Du.  MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism. , 2017, Best practice & research. Clinical haematology.

[27]  R. Verdijk.  Lymphoproliferative Tumors of the Ocular Adnexa , 2017, Asia-Pacific journal of ophthalmology.

[28]  F. Lee,et al.  Nasal dissemination of a single-clone IgH-rearranged conjunctival MALT lymphoma through the nasolacrimal duct: A case report. , 2016, Oncology letters.

[29]  H. Grossniklaus,et al.  Conjunctival Lymphoma--An International Multicenter Retrospective Study. , 2016, JAMA ophthalmology.

[30]  C. Margo,et al.  Extranodal Marginal Zone B-cell Lymphoma of the Ocular Adnexa. , 2016, Cancer control : journal of the Moffitt Cancer Center.

[31]  S. Tomlins,et al.  Comprehensive Genomic Profiling of Orbital and Ocular Adnexal Lymphomas Identifies Frequent Alterations in MYD88 and Chromatin Modifiers: New Routes to Targeted Therapies , 2016, Modern Pathology.

[32]  S. Heegaard,et al.  Malignant lymphoma of the conjunctiva. , 2015, Survey of ophthalmology.

[33]  T. Sullivan,et al.  The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease , 2015, Orbit.

[34]  C. Portell,et al.  The Role of Infectious Agents, Antibiotics, and Antiviral Therapy in the Treatment of Extranodal Marginal Zone Lymphoma and Other Low-Grade Lymphomas , 2015, Current Treatment Options in Oncology.

[35]  L. Specht,et al.  Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. , 2015, International journal of radiation oncology, biology, physics.

[36]  H. Grossniklaus,et al.  Ocular adnexal follicular lymphoma: a multicenter international study. , 2014, JAMA ophthalmology.

[37]  B. Esmaeli,et al.  Clinical value of magnetic resonance imaging and other baseline testing for conjunctival mucosa-associated lymphoid tissue lymphoma , 2014, Leukemia & lymphoma.

[38]  C. Shields,et al.  Choroidal lymphoma: clinical features and association with systemic lymphoma. , 2014, Ophthalmology.

[39]  Arun D. Singh,et al.  Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. , 2014, Ophthalmology.

[40]  S. Heegaard,et al.  Can conjunctival lymphoma be a clinical diagnosis? , 2013, British Journal of Ophthalmology.

[41]  Gala Beykin,et al.  Paediatric and adolescent elevated conjunctival lesions in the plical area: lymphoma or reactive lymphoid hyperplasia? , 2013, British Journal of Ophthalmology.

[42]  L. Rybicki,et al.  Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system. , 2013, Ophthalmology.

[43]  Sander R. Dubovy,et al.  Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas , 2013, American journal of hematology.

[44]  M. Raderer,et al.  Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. , 2013, Blood.

[45]  S. Donaldson,et al.  Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma. , 2013, International journal of radiation oncology, biology, physics.

[46]  Sander R. Dubovy,et al.  Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. , 2013, Ophthalmology.

[47]  S. Coupland,et al.  Molecular pathology of lymphoma , 2013, Eye.

[48]  P. Zinzani.  The many faces of marginal zone lymphoma. , 2012, Hematology. American Society of Hematology. Education Program.

[49]  B. Esmaeli,et al.  Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors. , 2012, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[50]  F. Cavalli,et al.  Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  P. Rubin,et al.  Conjunctival pediatric follicular lymphoma. , 2012, Archives of ophthalmology.

[52]  T. Matsuo,et al.  Conjunctival lymphoma can be detected by FDG PET. , 2012, Clinical nuclear medicine.

[53]  L. Larocca,et al.  Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results. , 2012, Ophthalmology.

[54]  K. Kwan,et al.  Choroidal lymphoma with orbital and optic nerve extension: case and review of literature. , 2012, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[55]  A. Azumi,et al.  Uveal extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type with concomitant extraocular lesions in a Japanese man , 2011, Japanese Journal of Ophthalmology.

[56]  A. Ferreri,et al.  Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas. , 2011, Ophthalmology.

[57]  A. Ferreri,et al.  Six‐month oral clarithromycin regimen is safe and active in extranodal marginal zone B‐cell lymphomas: final results of a single‐centre phase II trial , 2010, British journal of haematology.

[58]  B. Damato,et al.  A TNM-based clinical staging system of ocular adnexal lymphomas. , 2009, Archives of pathology & laboratory medicine.

[59]  A. Gebert,et al.  Conjunctiva-Associated Lymphoid Tissue – Current Knowledge, Animal Models and Experimental Prospects , 2009, Ophthalmic Research.

[60]  L. Sjö.  Ophthalmic lymphoma: epidemiology and pathogenesis , 2009, Acta ophthalmologica.

[61]  H. Müller-Hermelink,et al.  A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation‐negative MALT lymphoma of the ocular adnexa and salivary glands , 2009, The Journal of pathology.

[62]  B. Damato,et al.  Understanding intraocular lymphomas , 2008, Clinical & experimental ophthalmology.

[63]  Jae-Wook Yang,et al.  The association between conjunctival MALT lymphoma and Helicobacter pylori , 2008, British Journal of Ophthalmology.

[64]  Namju Kim,et al.  Primary diffuse large B-cell lymphoma of the palpebral conjunctiva. , 2007, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[65]  N. Harris,et al.  Lymphoma of the Ocular Adnexa: A Study of 353 Cases , 2007, The American journal of surgical pathology.

[66]  S. Heegaard,et al.  Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma. , 2007, Ophthalmology.

[67]  J. Fraumeni,et al.  Rapidly increasing incidence of ocular non-hodgkin lymphoma. , 2006, Journal of the National Cancer Institute.

[68]  D. de Jong,et al.  Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions , 2006, The Journal of pathology.

[69]  C. Doglioni,et al.  Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  H. Stein,et al.  Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases , 2005, British Journal of Ophthalmology.

[71]  Arzu Arslan,et al.  MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates. , 2005, European journal of radiology.

[72]  K. Colby,et al.  Treatment of Conjunctival Lymphomas , 2005, Seminars in ophthalmology.

[73]  Atul K. Jain,et al.  MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA WITH INTRAOCULAR INVOLVEMENT , 2005, Retina.

[74]  O. Becker,et al.  Doppelseitiges symmetrisch gelegenes Lymphadenom der Orbita , 1872, Albrecht von Graefes Archiv für Ophthalmologie.

[75]  D. Meller,et al.  Anti‐CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva , 2004, European journal of haematology.

[76]  Ming-Qing Du,et al.  MALT lymphoma: from morphology to molecules , 2004, Nature Reviews Cancer.

[77]  T. Matsuo,et al.  Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma. , 2004, Ophthalmology.

[78]  C. Shields,et al.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. , 2004, Ophthalmology.

[79]  S. Coupland.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines]. , 2004, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[80]  M. Tiemann,et al.  Mucosa-associated lymphoid tissue lymphoma in the conjunctiva of a child , 2004, Virchows Archiv.

[81]  T. Sullivan,et al.  Interferon treatment of childhood conjunctival lymphoma , 2003, The British journal of ophthalmology.

[82]  C. Regueiro,et al.  Treatment of conjunctival lymphomas by beta-ray brachytherapy using a strontium-90-yttrium-90 applicator. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[83]  P. Mckelvie,et al.  Ocular adnexal lymphoproliferative disease: a series of 73 cases , 2001, Clinical & experimental ophthalmology.

[84]  C. Shields,et al.  Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. , 2001, Ophthalmology.

[85]  John E. Wright,et al.  Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival , 2000, The British journal of ophthalmology.

[86]  H. Stein,et al.  T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. , 1999, Ophthalmology.

[87]  L. Baldini,et al.  Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[88]  C. Margo,et al.  Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. , 1998, Ophthalmology.

[89]  M. Cellini,et al.  Interferon Alpha in the Therapy of Conjunctival Lymphoma in An Hiv+ Patient , 1996, European journal of ophthalmology.

[90]  F. Fraunfelder,et al.  Cryotherapy for conjunctival lymphoid tumors. , 1994, American journal of ophthalmology.

[91]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[92]  P. Isaacson,et al.  Extranodal malignant lymphoma arising from mucosa‐associated lymphoid tissue , 1984, Cancer.

[93]  J. Berg,et al.  Occurrence and prognosis of extranodal lymphomas , 1972, Cancer.

[94]  M Tubiana,et al.  Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.

[95]  A. Feinstein,et al.  Ocular involvement in lymphomatous disease. , 1952, A.M.A. archives of ophthalmology.

[96]  L. F. Mcandrews,et al.  Lymphomas of the Conjunctiva , 1932 .

[97]  R. Wright.  LYMPHOMATA OF THE ORBIT. , 1929 .

[98]  A. J. Bedell.  Socalled Solid Edema; Lymphoma , 1922 .